Form 8-K - Current report:
SEC Accession No. 0001558370-25-002750
Filing Date
2025-03-12
Accepted
2025-03-12 09:00:15
Documents
19
Period of Report
2025-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20250312x8k.htm   iXBRL 8-K 69532
2 EX-3.1 dwtx-20250312xex3d1.htm EX-3.1 94042
3 EX-10.1 dwtx-20250312xex10d1.htm EX-10.1 68359
4 EX-10.2 dwtx-20250312xex10d2.htm EX-10.2 21748
5 EX-10.3 dwtx-20250312xex10d3.htm EX-10.3 82539
6 EX-99.1 dwtx-20250312xex99d1.htm EX-99.1 19900
7 GRAPHIC dwtx-20250312xex99d1001.jpg GRAPHIC 4788
  Complete submission text file 0001558370-25-002750.txt   552595

Data Files

Seq Description Document Type Size
8 EX-101.SCH dwtx-20250312.xsd EX-101.SCH 3396
9 EX-101.LAB dwtx-20250312_lab.xml EX-101.LAB 16579
10 EX-101.PRE dwtx-20250312_pre.xml EX-101.PRE 10502
21 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250312x8k_htm.xml XML 5040
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 25730121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)